Literature DB >> 11994695

Primary cellular immunodeficiencies.

Rebecca H Buckley1.   

Abstract

Genetic defects in T-cell function lead to susceptibility to infections or to other clinical problems that are more grave than those seen in disorders resulting in antibody deficiency alone. Those affected usually present during infancy with either common or opportunistic infections and rarely survive beyond infancy or childhood. The spectrum of T-cell defects ranges from the syndrome of severe combined immunodeficiency, in which T-cell function is absent, to combined immunodeficiency disorders in which there is some, but not adequate, T-cell function for a normal life span. Recent discoveries of the molecular causes of many of these defects have led to a new understanding of the flawed biology underlying the ever-growing number of defects. Most of these conditions could be diagnosed by means of screening for lymphopenia or for T-cell deficiency in cord blood at birth. Early recognition of those so afflicted is essential to the application of the most appropriate treatments for these conditions at a very early age. The latter treatments include both transplantation and gene therapy in addition to immunoglobulin replacement. Fully defining the molecular defects of such patients is also essential for genetic counseling of family members and prenatal diagnosis.

Entities:  

Mesh:

Year:  2002        PMID: 11994695     DOI: 10.1067/mai.2002.123617

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  15 in total

1.  A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID).

Authors:  Kee Chan; Joie Davis; Sung-Yun Pai; Francisco A Bonilla; Jennifer M Puck; Michael Apkon
Journal:  Mol Genet Metab       Date:  2011-07-12       Impact factor: 4.797

Review 2.  Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes.

Authors:  Shradha Agarwal; Lloyd Mayer
Journal:  J Allergy Clin Immunol       Date:  2009-08-08       Impact factor: 10.793

3.  Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists.

Authors:  E de Vries
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 4.  Using intravenous immunoglobulin (IVIG) to treat patients with primary immune deficiency disease.

Authors:  Vincent R Bonagura
Journal:  J Clin Immunol       Date:  2012-12-28       Impact factor: 8.317

5.  Calculating the dose of subcutaneous immunoglobulin for primary immunodeficiency disease in patients switched from intravenous to subcutaneous immunoglobulin without the use of a dose-adjustment coefficient.

Authors:  Michael Fadeyi; Tin Tran
Journal:  P T       Date:  2013-12

6.  Activation of B cells by antigens on follicular dendritic cells.

Authors:  Mohey Eldin M El Shikh; Rania M El Sayed; Selvakumar Sukumar; Andras K Szakal; John G Tew
Journal:  Trends Immunol       Date:  2010-04-24       Impact factor: 16.687

Review 7.  Fungal infections in primary immunodeficiencies.

Authors:  Charalampos Antachopoulos; Thomas J Walsh; Emmanuel Roilides
Journal:  Eur J Pediatr       Date:  2007-06-06       Impact factor: 3.183

8.  Primary immunodeficiency diseases in Egyptian children: a single-center study.

Authors:  Shereen M Reda; Hanaa M Afifi; Mai M Amine
Journal:  J Clin Immunol       Date:  2008-11-11       Impact factor: 8.317

9.  Patients with Idiopathic Pulmonary Nontuberculous Mycobacterial Disease Have Normal Th1/Th2 Cytokine Responses but Diminished Th17 Cytokine and Enhanced Granulocyte-Macrophage Colony-Stimulating Factor Production.

Authors:  Un-In Wu; Kenneth N Olivier; Douglas B Kuhns; Danielle L Fink; Elizabeth P Sampaio; Adrian M Zelazny; Shamira J Shallom; Beatriz E Marciano; Michail S Lionakis; Steven M Holland
Journal:  Open Forum Infect Dis       Date:  2019-11-28       Impact factor: 3.835

10.  X-linked severe combined immunodeficiency (X-SCID) with high blood levels of immunoglobulins and Aspergillus pneumonia successfully treated with micafangin followed by unrelated cord blood stem cell transplantation.

Authors:  Shinichi Kobayashi; Shizuko Murayama; Osamu Tatsuzawa; Goro Koinuma; Kazuteru Kawasaki; Chikako Kiyotani; Masaaki Kumagai
Journal:  Eur J Pediatr       Date:  2006-08-17       Impact factor: 3.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.